Free guide · De-addiction & rehabilitation centres · Union Territory
J&K just became the most tightly regulated jurisdiction in this guide series. On 2 April 2026, barely four months before this guide was researched, the J&K Government notified its first-ever comprehensive de-addiction centre law — arguably the most detailed of any state or UT covered here — complete with mandatory CCTV, a Quality-Assurance Cell in every centre, and a 24-hour police-reporting requirement for deaths.
Before 2019, J&K ran its own much older law: the Jammu and Kashmir Nursing Homes and Clinical Establishments (Registration and Licensing) Act, 1963, predating the rest of India's central framework by nearly five decades. Following the reorganisation of the state into the Union Territories of Jammu & Kashmir and Ladakh in 2019, and the broader harmonisation of J&K's laws with the rest of India, the UT now appears on the national list of jurisdictions covered by the central Clinical Establishments (Registration and Regulation) Act, 2010, alongside Ladakh. The J&K Health and Medical Education Department has itself issued advisories on verifying private nursing homes and clinics under this central Act, confirming the transition is operationally real, not just a formality on paper.
This is the headline development for anyone planning a centre in J&K right now. The Jammu and Kashmir Substance Use Disorder Treatment, Counselling and Rehabilitation Centre Rules, 2026, notified on 2 April 2026 under S.O. 91, framed under the NDPS Act, 1985, is J&K's first comprehensive framework to regulate and professionalise substance abuse treatment. It is unusually detailed even by the standards of this guide series.
No centre may operate without a licence from the Director Health Services (Jammu or Kashmir). Licence term is three years, renewable only after inspection and satisfactory compliance.
Minimum 400 sq ft per 10 indoor beds. Separate male and female wards. Dedicated counselling and OPD rooms. Emergency detoxification beds under continuous medical supervision.
In all critical areas, with footage retained for a minimum of 90 days.
No centre may operate in a residential area without both municipal and police clearance.
At least one full-time or part-time psychiatrist, one MBBS Medical Officer with addiction-medicine training, one Clinical Psychologist per 15 patients, one Nurse per 10 patients, and qualified social workers/counsellors.
Mandatory in every centre, specifically to verify correct dosages, check expiry dates, and ensure proper storage of controlled drugs.
Must be reported within 48 hours to the Licensing Authority and a Pharmacovigilance Cell.
Must be reported within 24 hours to the nearest police station, the district Chief Medical Officer, and the Licensing Authority simultaneously.
A UT-level monitoring committee, drawing members from Health and Medical Education, Law/Justice/Parliamentary Affairs, Social Welfare, and Police (Narcotics), reviews performance and compliance. Treatment must be voluntary — forced or involuntary admission is explicitly banned except under judicial or medical certification, a direct echo of the Mental Healthcare Act's supported-admission safeguards.
Parallel to the 2026 Rules, J&K also runs the standard Mental Healthcare Act, 2017 registration track. The Jammu and Kashmir Mental Healthcare (Mental Health Authority) Rules, 2023 were notified by Lieutenant Governor Manoj Sinha under Section 121(2) of the Act, establishing the J&K Mental Health Authority. Its Selection Committee for non-official members includes the Head of the Department of Psychiatry at Government Medical College (Srinagar or Jammu) and the Mission Director, National Health Mission, J&K, giving the UT's own psychiatric leadership direct input into who sits on the Authority.
The Authority can audit registered Mental Health Establishments itself, or delegate this to a representative from the Deputy Commissioner's office, the J&K UT Human Rights Commission, or practising psychiatrists, and may conduct inspections suo motu or on complaint. In practice, expect a centre offering inpatient or residential care in J&K to need both this registration and the new 2026 licence — they cover overlapping but legally distinct requirements.
This is not something found in any other jurisdiction covered in this guide series. In September 2025, the Jammu and Kashmir Medical Council (JKMC) issued a notification citing "reported misuse" of privately owned de-addiction clinics, requiring that any medical practitioner seeking permanent JKMC registration for the purpose of providing de-addiction treatment, or prescribing and dispensing Buprenorphine-Naloxone or similar narcotic or psychotropic substances, must furnish an affidavit sworn before a Judicial Magistrate First Class in a prescribed format.
This is a practitioner-level accountability measure, separate from and additional to your centre's own licensing under Tracks 2 and 3. It means your recruiting and credentialing process needs to budget for this step specifically for any doctor who will prescribe substitution medication — it is not something a doctor can do retroactively in a hurry if the licensing authority asks to see it.
If you're pursuing government funding rather than a private licence, the route is the Ministry of Social Justice and Empowerment's National Action Plan for Drug Demand Reduction. J&K is a special-category UT for this purpose, alongside the North-Eastern states, Sikkim and Ladakh, meaning eligible NGOs can access grant-in-aid up to 95 percent rather than the standard 90 percent.
What's already running: per a recent Ministry reply to the Rajya Sabha, 21 Addiction Treatment Facilities (ATFs) are currently functional across all districts of J&K, with psychiatry departments equipped for addiction treatment at Government Medical Colleges in Jammu, Kathua, Udhampur, Rajouri, Doda, Anantnag, Baramulla, Handwara and Bemina. District De-Addiction Centre (DDAC) grants under NAPDDR have been sanctioned for Poonch, Kathua and Shopian districts, with rent-free accommodation provided by the respective District Administrations. Counselling is also delivered through District Early Intervention Centres and integrated with the national Tele-MANAS programme.
The Institute of Mental Health and Neurosciences (IMHANS), Srinagar is J&K's nodal institution for psychiatric treatment, training and workforce development, and the natural reference point and potential referral partner for anyone building a centre here. Originally the Department of Psychiatry at Government Medical College Srinagar (established in the 1970s), it was upgraded under the National Mental Health Programme in 2009. It now operates as a 160-bed Centre of Excellence, spanning a facility at Rainawari and a Community General Hospital Unit within the SMHS Hospital complex.
A separate 20-bed unit at SMHS Hospital, running in collaboration with AIIMS New Delhi, which supplies free medicines for outpatients. The clinic sees roughly 200 to 250 patients a day in OPD, has around 5,112 total registered patients, and provides registration, follow-up, counselling (individual, group and family), medicine dispensing, overdose emergency response, and field visits. A 10-bed inpatient Addiction Treatment Facility has also been approved and developed on the IMHANS campus in recent years.
Per a recent government reply: roughly 120 psychiatrists and 40 clinical psychologists work across government and private institutions in J&K, of which about 71 psychiatrists and 10 clinical psychologists are in government service. A new MD Psychiatry programme has been initiated at Government Medical College, Jammu, to help expand this pipeline.
J&K is unusual in that its Police force directly operates dedicated de-addiction facilities, not just referral or enforcement roles. The Police Drug De-Addiction and Rehabilitation Centre, Srinagar and the Police Drug De-addiction, Rehabilitation & Mental Health Care Centre, Jammu both function as active treatment centres, using counselling, yoga, exercise and medication under psychiatrists, psychologists, counsellors and general physicians. If you're building relationships across the ecosystem here, these are worth knowing as both a model of care and a potential referral partner, reflecting how directly J&K's security apparatus has been drawn into the substance-use response.
The Jammu and Kashmir Substance Use Disorder Treatment, Counselling and Rehabilitation Centre Rules, 2026, notified on 2 April 2026 under S.O. 91, framed under the NDPS Act, 1985. This is J&K's first-ever comprehensive de-addiction centre law, requiring mandatory CCTV, a Quality-Assurance Cell in every centre, and a 24-hour police-reporting requirement for deaths.
The Director Health Services, Jammu or Kashmir (matching your centre's location), or another officer the Government may notify. The licence is valid for three years and renewable only after inspection and satisfactory compliance.
In September 2025, the Jammu and Kashmir Medical Council required that any medical practitioner providing de-addiction treatment or prescribing Buprenorphine-Naloxone or similar controlled substances must furnish an affidavit sworn before a Judicial Magistrate First Class in a prescribed format. This is a practitioner-level requirement on top of your centre's own licensing.
A minimum of 400 sq ft per 10 indoor beds, plus separate male and female wards, dedicated counselling and OPD rooms, and emergency detoxification beds under continuous medical supervision.
No. The 2026 Rules explicitly ban forced or involuntary admission except under judicial or medical certification, a direct echo of the Mental Healthcare Act's supported-admission safeguards.
Within 24 hours, to the nearest police station, the district Chief Medical Officer, and the Licensing Authority simultaneously. Adverse drug reactions must be reported within 48 hours to the Licensing Authority and a Pharmacovigilance Cell.
Every centre already operating when the Rules were notified in April 2026 had six months to apply for a licence, meaning the compliance window closes around October 2026.
Yes. J&K is a special-category UT, alongside the North-Eastern states, Sikkim and Ladakh, meaning eligible NGOs can access grant-in-aid up to 95 percent of eligible costs rather than the standard 90 percent.
The Institute of Mental Health and Neurosciences (IMHANS), Srinagar, is J&K's nodal psychiatric institution. Its Drug Treatment Clinic at SMHS Hospital sees 200–250 OPD patients a day and runs in collaboration with AIIMS New Delhi. It is the natural clinical protocol, training and referral partner for any serious private centre in J&K.
The 2026 Rules require real-time adverse-event logging, a Quality-Assurance Cell, and controlled-substance records that inspectors can review on the spot. MindFlow builds all of that into your normal clinical workflow.
See the de-addiction suite →Informational, not legal advice. Reflects publicly available sources as of August 2026, most significantly a de-addiction centre law only four months old at the time of writing, meaning implementation details, application forms, and inspection procedures are still actively being worked out and may not yet be fully public. Confirm current requirements directly with the Director Health Services (Jammu or Kashmir), the J&K Mental Health Authority, the J&K Medical Council, and a lawyer qualified in Indian health and narcotics law before making licensing or investment decisions.